Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-tubulin complex component 3 (TUBGCP3) is a cytoplasmic protein that is a core constituent of the gamma-tubulin ring complex (γ-TuRC), which mediates microtubule nucleation at the centrosome[1][4]. TUBGCP3 binds directly to gamma-tubulin and is involved in the assembly and function of γ-TuSC and γ-TuRC, which are essential for proper spindle pole formation and cell cycle progression during both mitosis and meiosis[1][3][4]. Loss or depletion of TUBGCP3 disrupts microtubule nucleation, causing mitotic defects, abnormal spindle assembly, cell cycle arrest, and apoptosis[3]. Mutations or dysregulation of TUBGCP3 have been implicated in developmental disorders (including primary autosomal recessive microcephaly), certain cancers, neurodevelopmental defects, and Parkinson’s disease[1][3]. To date, TUBGCP3 itself is not considered a common direct therapeutic target and there are no known interacting drugs or biomarker uses in clinical practice[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-tubulin complex component 3 (TUBGCP3).